Susceptibility testing of macrolide and lincosamide antibiotics according to DIN guidelines

Journal of Antimicrobial Chemotherapy

Volumn 40, Issue 2, 1997, Pages 179-187

  Schmalreck, A F ^a   Kottmann, I ^a   Reiser, A ^a   Ruffer, U ^a   Schlenk, R ^a   Vanca, E ^a   Wildfeuer, A ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; JOSAMYCIN; LINCOSAMIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; MIDECAMYCIN; ROXITHROMYCIN;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRACTICE GUIDELINE;

ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; GUIDELINES; HAEMOPHILUS INFLUENZAE; HUMANS; MACROLIDES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 0030830060     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/40.2.179     Document Type: Article

References (20)

1. Cleary, T. J., Villa, S., Sands, L. & Hoffmann, T. A. (1978). Comparative in vitro activity of josamycin, erythromycin, clindamycin and penicillin. Current Therapeutic Research 23, 351-7.
2. Kirst, H. A. & Sides, G. D. (1989). New macrolides: new directions for macrolide antibiotics: structural modifications and in vitro activity. Antimicrobial Agents and Chemotherapy 33, 1413-8.
3. Kobayashi, Y. (1987). Miokamycin (midecamycinacetate), a newly developed macrolide antibiotic in Japan. Drugs of Today 23, 505-6.
4. Modai, J. (1985). Comparative evaluation of macrolides, lincosamides and streptogramins in staphylococcal infections. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 195-7.
5. Baron, E. J. (1992) The detection, significance, and rationale for control of methicillin-resistant Staphylococcus aureus. Clinical Microbiology Ne wsletter 14, 129-33.
6. Osono, T. & Umezawa, H. (1985). Pharmacokinetics of macrolides, lincosamides and streptogramins. Journal of Antimicrobial Chemotherapy 16, Suppl. A, 151-66.
7. Sörgel, F., Kinzig, M. & Hüner, L. (1993). Pharmakokinetik der Makrolide. Chemotherapie 2, Suppl. 2, 28-44.
8. National Committee for Clinical Laboratory Standards. (1995). Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M100-S6. NCCLS, Villanova, PA.
9. Deutsches Institut für Normung. (1989). Medical Microbiology -Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents: Agar Diffusion Test. DIN 58940 Part 3. Deutsches Institut für Normung e.V., Beuth Verlag, Berlin.
10. Deutsches Institut für Normung. (1990). Medical Microbiology - Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents: Determination of Minimum Inhibitory Concentrations by the Agar Dilution Method. DIN 58940 Part 6. Deutsches Institut für Normung e.V., Beuth Verlag, Berlin.
11. Deutsches Institut für Normung. (1990). Medical Microbiology - Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents: Microdilution. DIN 58940 Part 8. Deutsches Institut für Normung e.V., Beuth Verlag, Berlin.
12. Deutsches Institut für Normung. (1990). Medical Microbiology - Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents: Carrier of Agents for the Agar Diffusion Test. DIN 58940 Part 2. Deutsches Institut für Normung e.V., Beuth Verlag, Berlin.
13. Deutsches Institut für Normung. (1990). Medical Microbiology - Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents: Regression Analysis for the Correlation of Inhibition Zone Diameters and Minimum Inhibitory Concentration. DIN 58940 Part 9. Deutsches Institut für Normung e.V., Beuth Verlag, Berlin.
14. National Committee for Clinical Laboratory Standards. (1994). Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A4. NCCLS, Villanova, PA.
15. Metzler, C. M. & DeHaan, R. M. (1974). Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. Journal of Infectious Diseases 130, 588-94.
16. Doern, G. V., Jorgensen, J. H., Thornsberry, C. & Snapper, H. (1990). Disk diffusion susceptibility testing of Haemophilus influenzae using Haemophilus test medium. European Journal of Clinical Microbiology and Infectious Diseases 9, 329-36.
17. Barry, A. L., Jones, R. N. & Thornsberry, C. (1988). In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. Antimicrobial Agents and Chemotherapy 32, 752-4.
18. Champney, W. S. & Burdine, R. (1995). Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 39, 2141-4.
19. Weisblum, B. (1995). Insights into erythromycin action from studies of its activity as inducer of resistance. Antimicrobial Agents and Chemotherapy 39, 797-805.
20. Acar, J., Chardon, H., Choutet, P., Courvalin, P., Dabernat, H., Drugeon, H. et al. (1995). Communiqué 1995 - Comité de l'Antibiogramme de la Societé Française de Microbiologie. Pathologie Biologie 43(8), I-VIII.